Friday, January 27, 2023

Tag: Lundbeck

New Medications Fail to Show Efficacy for Alzheimer’s Disease

13
Three phase III clinical trials assessing the efficacy of Lundbeck’s investigational drug idalopirdine for Alzheimer’s disease have failed